{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T20:24:25Z","timestamp":1784233465632,"version":"3.55.0"},"reference-count":16,"publisher":"Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,5,20]]},"DOI":"10.31744\/einstein_journal\/2022ao5587","type":"journal-article","created":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T12:20:15Z","timestamp":1653308415000},"source":"Crossref","is-referenced-by-count":4,"title":["Effects of topiramate, bupropion and naltrexone isolated or combined on subcutaneous adipose tissue in obese rats"],"prefix":"10.31744","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1022-6527","authenticated-orcid":false,"given":"Monica Alhadas","family":"Scudeler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2702-6310","authenticated-orcid":false,"given":"Stephania","family":"Morreale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3780-1042","authenticated-orcid":false,"given":"Lorena","family":"Doretto-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6078-9184","authenticated-orcid":false,"given":"Giuliana","family":"Petri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0863-533X","authenticated-orcid":false,"given":"Jos\u00e9 Francisco Ramos dos","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5054-0721","authenticated-orcid":false,"given":"Cristina","family":"Nassis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1563-6621","authenticated-orcid":false,"given":"Olga Maria de Toledo","family":"Correa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5096-7098","authenticated-orcid":false,"given":"Juliana Mora","family":"Veridiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"16942","reference":[{"issue":"1","key":"key20220523082012_B1","first-page":"1","article-title":"Obesity in adolescence: aspects of membership and stay in treatment program multiprofessional marked in therapy comportametal","volume":"9","author":"Barbieri","year":"2011","unstructured":"Barbieri AF. Obesity in adolescence: aspects of membership and stay in treatment program multiprofessional marked in therapy comportametal. Conex\u00f5es (Campinas, Online). 2011;9(1):1-23.","journal-title":"Conex\u00f5es (Campinas, Online)"},{"issue":"2","key":"key20220523082012_B2","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/oby.2001.13","article-title":"Development of a brief measure to assess quality of life in obesity","volume":"9","author":"Kolotkin","year":"2001","unstructured":"Kolotkin RL, Crosby RD, Kosloski KD, Williams GR. Development of a brief measure to assess quality of life in obesity. Obes Res. 2001;9(2):102-11.","journal-title":"Obes Res"},{"key":"key20220523082012_B3","first-page":"252","volume-title":"Report of a WHO consultation","author":"World Health Organization (WHO)","year":"2000","unstructured":"World Health Organization (WHO). Obesity: preventing and managing the global epidemic. Report of a WHO consultation. Geneva: WHO; 2000. p. 252 [cited 2020 Aug 17]. [WHO Technical Report Series 894]. Available from: https:\/\/www.who.int\/nutrition\/publications\/obesity\/WHO_TRS_894\/en\/"},{"issue":"3","key":"key20220523082012_B4","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1590\/S0102-311X2004000300006","article-title":"Aspectos das pr\u00e1ticas alimentares e da atividade f\u00edsica como determinantes do crescimento do sobrepeso\/obesidade no Brasil","volume":"20","author":"Mendon\u00e7a","year":"2004","unstructured":"Mendon\u00e7a CP, dos Anjos LA. Aspectos das pr\u00e1ticas alimentares e da atividade f\u00edsica como determinantes do crescimento do sobrepeso\/obesidade no Brasil. Cad Saude Publica. 2004;20(3):698-709. Review.","journal-title":"Cad Saude Publica"},{"issue":"13","key":"key20220523082012_B5","first-page":"63","article-title":"Consumo alimentar de fam\u00edlias de baixa renda no munic\u00edpio de Piracicaba\/SP","volume":"6","author":"Motta","year":"2004","unstructured":"Motta DG, Peres MT. Consumo alimentar de fam\u00edlias de baixa renda no munic\u00edpio de Piracicaba\/SP. Rev Bras Educ Espec. 2004;6(13):63-70.","journal-title":"Rev Bras Educ Espec"},{"issue":"6","key":"key20220523082012_B6","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1590\/S0004-27302010000600003","article-title":"Progressos recentes e novas perspectivas em farmacoterapia da obesidade","volume":"54","author":"Faria","year":"2010","unstructured":"Faria AM, Mancini MC, Melo ME, Cercato C, Halpern A. Progressos recentes e novas perspectivas em farmacoterapia da obesidade. Arq Bras Endocrinol Metabol. 2010;54(6):516-29. Review.","journal-title":"Arq Bras Endocrinol Metabol"},{"issue":"S1","key":"key20220523082012_B7","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1002\/2327-6924.12519","article-title":"Current pharmacotherapies for obesity: a practical perspective","volume":"29","author":"Golden","year":"2017","unstructured":"Golden A. Current pharmacotherapies for obesity: a practical perspective. J Am Assoc Nurse Pract. 2017;29(S1):S43-S52. Review.","journal-title":"J Am Assoc Nurse Pract"},{"issue":"2","key":"key20220523082012_B8","doi-asserted-by":"crossref","first-page":"129","DOI":"10.2217\/fca.15.79","article-title":"Naltrexone\/bupropion for the treatment of obesity and obesity with type 2 diabetes","volume":"12","author":"Apovian","year":"2016","unstructured":"Apovian CM. Naltrexone\/bupropion for the treatment of obesity and obesity with type 2 diabetes. Future Cardiol. 2016;12(2):129-38. Review.","journal-title":"Future Cardiol"},{"key":"key20220523082012_B9","doi-asserted-by":"crossref","first-page":"167S","DOI":"10.1038\/oby.2004.284","article-title":"Topiramate: a new potential pharmacological treatment for obesity","volume":"12","author":"Astrup","year":"2004","unstructured":"Astrup A, Toubro S. Topiramate: a new potential pharmacological treatment for obesity. Obes Res. 2004;12 Suppl:167S-73S. Review.","journal-title":"Obes Res"},{"issue":"1","key":"key20220523082012_B10","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/14740338.2017.1247807","article-title":"Safety assessment of combination therapies in the treatment of obesity: focus on naltrexone\/bupropion extended release and phentermine-topiramate extended release","volume":"16","author":"Halpern","year":"2017","unstructured":"Halpern B, Mancini MC. Safety assessment of combination therapies in the treatment of obesity: focus on naltrexone\/bupropion extended release and phentermine-topiramate extended release. Expert Opin Drug Saf. 2017;16(1):27-39. Review.","journal-title":"Expert Opin Drug Saf"},{"issue":"3","key":"key20220523082012_B11","doi-asserted-by":"crossref","first-page":"205","DOI":"10.7861\/clinmedicine.19-3-205","article-title":"Current treatments for obesity","volume":"19","author":"Ruban","year":"2019","unstructured":"Ruban A, Stoenchev K, Ashrafian H, Teare J. Current treatments for obesity. Clin Med (Lond). 2019;19(3):205-12.","journal-title":"Clin Med (Lond)"},{"issue":"10","key":"key20220523082012_B12","first-page":"1117","article-title":"Contrave, a bupropion and naltrexone combination therapy for the potential treatment of obesity","volume":"10","author":"Padwal","year":"2009","unstructured":"Padwal R. Contrave, a bupropion and naltrexone combination therapy for the potential treatment of obesity. Curr Opin Investig Drugs. 2009;10(10):1117-25. Review.","journal-title":"Curr Opin Investig Drugs"},{"key":"key20220523082012_B13","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0074-7696(08)61637-X","article-title":"Stereological principles for morphometry in electron microscopic cytology","volume":"26","author":"Weibel","year":"1969","unstructured":"Weibel ER. Stereological principles for morphometry in electron microscopic cytology. Int Rev Cytol. 1969;26:235-302. Review.","journal-title":"Int Rev Cytol"},{"issue":"5","key":"key20220523082012_B14","first-page":"255","article-title":"Naltrexone SR\/bupropion SR (Contrave): a new approach to weight loss in obese adults","volume":"36","author":"Ornellas","year":"2011","unstructured":"Ornellas T, Chavez B. Naltrexone SR\/bupropion SR (Contrave): a new approach to weight loss in obese adults. P T. 2011;36(5):255-62.","journal-title":"P T"},{"key":"key20220523082012_B15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.phrs.2014.04.004","article-title":"Naltrexone\/bupropion for obesity: an investigational combination pharmacotherapy for weight loss","volume":"84","author":"Billes","year":"2014","unstructured":"Billes SK, Sinnayah P, Cowley MA. Naltrexone\/bupropion for obesity: an investigational combination pharmacotherapy for weight loss. Pharmacol Res. 2014;84:1-11. Review.","journal-title":"Pharmacol Res"},{"issue":"4","key":"key20220523082012_B16","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.psc.2011.08.013","article-title":"Drug treatment of obesity","volume":"34","author":"Bray","year":"2011","unstructured":"Bray GA, Ryan DH. Drug treatment of obesity. Psychiatr Clin North Am. 2011; 34(4):871-80.","journal-title":"Psychiatr Clin North Am"}],"container-title":["einstein (S\u00e3o Paulo)"],"original-title":[],"language":"en","deposited":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T12:20:36Z","timestamp":1653308436000},"score":1,"resource":{"primary":{"URL":"https:\/\/journal.einstein.br\/article\/effects-of-topiramate-bupropion-and-naltrexone-isolated-or-combined-on-subcutaneous-adipose-tissue-in-obese-rats\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":16,"alternative-id":["10.31744\/einstein_journal\/2022AO5587"],"URL":"https:\/\/doi.org\/10.31744\/einstein_journal\/2022ao5587","relation":{},"ISSN":["1679-4508","2317-6385"],"issn-type":[{"value":"1679-4508","type":"print"},{"value":"2317-6385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]},"article-number":"eAO5587"}}